down arrow

Oxygenta Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE102E01018
  • NSEID:
  • BSEID: 524636
INR
77.00
-1 (-1.28%)
BSENSE

Apr 11, 12:48 PM

BSE+NSE Vol: 1.79 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

75.4078.25

52 Week

30.00108.64
Valuation
Technical
Day's Volume

CASH

1.79 k (4.70%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.03%

Held by 0 DIIs

Promoter

51.12%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of 35.68% and Operating profit at 0% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at 0 times
2

Risky - Negative EBITDA

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 289 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-2.84

stock-summary
Return on Equity

1.84%

stock-summary
Price to Book

-14.33

Revenue and Profits (1 Year):
Net Sales:
33 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-4 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-11.93%
0%
-11.93%
1 Year
94.89%
0%
94.89%
2 Years
133.05%
0%
133.05%
3 Years
216.87%
0%
216.87%
4 Years
954.79%
0%
954.79%
5 Years
954.79%
0%
954.79%

Oxygenta Pharma for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
35.68%
EBIT Growth (5y)
-17.32%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
0.76
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.03%
ROCE (avg)
-42.44%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
-14.33
EV to EBIT
-27.49
EV to EBITDA
-34.87
EV to Capital Employed
9.34
EV to Sales
4.91
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-33.41%
ROE (Latest)
Negative BV
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 3 Schemes (0.03%)

FIIs

Held by 0 FIIs

Promoter with highest holding

M V S Prasad Reddy (25.56%)

Highest Public shareholder

Sravani Reddy Gantla (12.13%)

Individual Investors Holdings

43.92%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 262.95% vs 16.56% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is -3.97% vs -16.31% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "33.21",
          "val2": "9.15",
          "chgp": "262.95%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-4.35",
          "val2": "-2.47",
          "chgp": "-76.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.39",
          "val2": "0.36",
          "chgp": "8.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.05",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-3.93",
          "val2": "-3.78",
          "chgp": "-3.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-13.10%",
          "val2": "-26.99%",
          "chgp": "13.89%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 33.55% vs 33.38% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 45.34% vs -91.56% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "26.63",
          "val2": "19.94",
          "chgp": "33.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.95",
          "val2": "-5.62",
          "chgp": "29.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.10",
          "val2": "0.64",
          "chgp": "71.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.16",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-4.22",
          "val2": "-7.72",
          "chgp": "45.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-14.83%",
          "val2": "-28.18%",
          "chgp": "13.35%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 105.71% vs 27.59% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 29.13% vs -57.97% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "59.84",
          "val2": "29.09",
          "chgp": "105.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-8.30",
          "val2": "-8.09",
          "chgp": "-2.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.49",
          "val2": "1.00",
          "chgp": "49.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.21",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-8.15",
          "val2": "-11.50",
          "chgp": "29.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-13.87%",
          "val2": "-27.81%",
          "chgp": "13.94%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 27.91% vs -48.79% in Mar 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 69.92% vs -1,796.72% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "39.64",
          "val2": "30.99",
          "chgp": "27.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-9.70",
          "val2": "-7.12",
          "chgp": "-36.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.59",
          "val2": "1.49",
          "chgp": "6.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.04",
          "val2": "-0.73",
          "chgp": "105.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-3.48",
          "val2": "-11.57",
          "chgp": "69.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-24.47%",
          "val2": "-22.98%",
          "chgp": "-1.49%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
33.21
9.15
262.95%
Operating Profit (PBDIT) excl Other Income
-4.35
-2.47
-76.11%
Interest
0.39
0.36
8.33%
Exceptional Items
0.00
-0.05
100.00%
Standalone Net Profit
-3.93
-3.78
-3.97%
Operating Profit Margin (Excl OI)
-13.10%
-26.99%
13.89%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 262.95% vs 16.56% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Dec 2024 is -3.97% vs -16.31% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
26.63
19.94
33.55%
Operating Profit (PBDIT) excl Other Income
-3.95
-5.62
29.72%
Interest
1.10
0.64
71.88%
Exceptional Items
0.00
-0.16
100.00%
Standalone Net Profit
-4.22
-7.72
45.34%
Operating Profit Margin (Excl OI)
-14.83%
-28.18%
13.35%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 33.55% vs 33.38% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 45.34% vs -91.56% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
59.84
29.09
105.71%
Operating Profit (PBDIT) excl Other Income
-8.30
-8.09
-2.60%
Interest
1.49
1.00
49.00%
Exceptional Items
0.00
-0.21
100.00%
Standalone Net Profit
-8.15
-11.50
29.13%
Operating Profit Margin (Excl OI)
-13.87%
-27.81%
13.94%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 105.71% vs 27.59% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 29.13% vs -57.97% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
39.64
30.99
27.91%
Operating Profit (PBDIT) excl Other Income
-9.70
-7.12
-36.24%
Interest
1.59
1.49
6.71%
Exceptional Items
0.04
-0.73
105.48%
Standalone Net Profit
-3.48
-11.57
69.92%
Operating Profit Margin (Excl OI)
-24.47%
-22.98%
-1.49%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 27.91% vs -48.79% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is 69.92% vs -1,796.72% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Oxygenta Pharmaceutical Ltd stock-summary
stock-summary
Oxygenta Pharmaceutical Ltd
Micro Cap
Pharmaceuticals & Drugs
Oxygenta Pharmaceutical Limited (Formerly known S S Organics Ltd) was incorporated as Private Limited Company in year 1990 and converted into a Limited Company in 1993, with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals. Later, the Company changed its name from S.S. Organics Ltd. to Oxygenta Pharmaceutical Limited in 2021-22.
Company Coordinates stock-summary
Company Details
Survey No 252/1 Aroor Village, Sadasivapet Mandal Medak Telangana : 502291
stock-summary
Tel: 91-08455-250080/250280
stock-summary
http://oxygentapharma.com
stock-summary
info@ssorganics.co.in
Registrar Details
Venture Capital & Corporate Investments Ltd , 12-10-167,, MIG- 167,, Bharat Nagar Colony, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."